Nymox Pharmaceutical Corporation (NYMXF)

Nymox Pharmaceutical Market Cap

Nymox Pharmaceutical has a market cap or net worth of $21.44 million as of July 3, 2024. Its market cap has decreased by -45.99% in one year.

• Market Cap: 21.44M
• Enterprise Value: 21.20M
• 1-Year Change: -45.99%
• Ranking: n/a
• Category: Nano-Cap
• Stock Price: $0.20

Market Cap Chart

Since December 1, 1998, Nymox Pharmaceutical's market cap has decreased from $106.00M to $21.44M, a decrease of -79.77%. That is a compound annual growth rate of -6.29%.

Market Cap History

Date	Market Cap	% Change
Jul 6, 2023	18.10M	-38.64%
Dec 30, 2022	29.50M	-73.13%
Dec 31, 2021	109.80M	-37.83%
Dec 31, 2020	176.60M	24.10%
Dec 31, 2019	142.30M	92.56%
Dec 31, 2018	73.90M	-54.41%
Dec 29, 2017	162.10M	41.20%
Dec 30, 2016	114.80M	-2.46%
Dec 31, 2015	117.70M	746.76%
Dec 31, 2014	13.90M	-93.18%
Dec 31, 2013	203.80M	-9.94%
Dec 31, 2012	226.30M	-15.50%
Dec 30, 2011	267.80M	21.62%
Dec 31, 2010	220.20M	60.03%
Dec 31, 2009	137.60M	37.88%
Dec 31, 2008	99.80M	-38.81%
Dec 31, 2007	163.10M	79.43%
Dec 29, 2006	90.90M	69.59%
Dec 30, 2005	53.60M	-21.87%
Dec 31, 2004	68.60M	-11.83%
Dec 31, 2003	77.80M	1.17%
Dec 31, 2002	76.90M	-7.79%
Dec 31, 2001	83.40M	114.95%
Dec 29, 2000	38.80M	-24.22%
Dec 31, 1999	51.20M	-45.06%

View and export this data all the way back to 1998. Sign Up Today.

Related Stocks

Company	Market Cap
Eli Lilly	869.02B
Novo Nordisk	643.38B
UnitedHealth Group	455.27B
Johnson & Johnson	352.43B
Merck & Co.	323.90B
AbbVie	300.85B
AstraZeneca	241.65B
Novartis AG	208.44B